Package Leaflet: Information for the User
Tiorfan 100 mg Hard Capsules
racecadotril
Read the entire package leaflet carefully before starting to take this medication.
Contents of the Package Leaflet:
Tiorfan is a medication for the treatment of diarrhea.
Tiorfan is used to treat the symptoms of acute diarrhea in adults when the causes of diarrhea cannot be treated.
If causal treatment is possible, racecadotril may be administered as complementary treatment.
Do not take Tiorfan
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tiorfan if:
The active ingredient of Tiorfan, racecadotril, may cause an allergic reaction called angioedema, which can cause swelling of the face, lips, throat, or tongue. If you experience these side effects, stop treatment immediately and contact your doctor. Swelling can occur at any time during treatment with this product.
Taking this product with other medications may increase the risk of angioedema (see "Other medications and Tiorfan").
Skin reactions have been reported with the use of this product. In most cases, they are mild and do not require treatment. In some cases, severe skin reactions may occur. In these cases, treatment with Tiorfan should be stopped immediately, and the patient should not take it again.
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with treatment with racecadotril. Stop using racecadotril and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Using Tiorfan with other medications
Please inform your doctor if you are using, have recently used, or may need to use any other medication.
Especially inform your doctor if you are taking any of the following medications, as they may increase the risk of side effects (see "Warnings and precautions"):
Pregnancy and breastfeeding
Tiorfan is not recommended if you are pregnant or think you may be pregnant, or if you are breastfeeding.
Consult your doctor or pharmacist before using any medication.
Driving and using machines
Tiorfan has little or no effect on the ability to drive or operate machinery.
Tiorfan contains lactose
Tiorfan contains lactose (a type of sugar). If your doctor has told you that you have an intolerance to some sugars, ask your doctor before taking Tiorfan.
This medication does not contain gluten.
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The usual dose is one capsule three times a day, which should be swallowed with a glass of water.
Tiorfan is available in the form of hard capsules.
The usual dose is one capsule three times a day, which should be swallowed with a glass of water. Tiorfan should be taken preferably before main meals, but to start treatment, you can take one Tiorfan capsule at any time of the day.
Your doctor will indicate the duration of treatment with Tiorfan. Treatment should be continued until two normal stools are produced, not exceeding 7 days.
To compensate for fluid loss due to diarrhea, this medication should be used along with adequate fluid and electrolyte replacement. The best replacement of fluids and salts is achieved with an oral rehydration solution (please ask your doctor or pharmacist if you are unsure).
No dose adjustment is required in the elderly.
Children
Other forms of Tiorfan are available for use in children and babies.
If you take more Tiorfan than you should
If you take more Tiorfan than you should, please contact your doctor or pharmacist immediately.
If you forget to take Tiorfan
Do not take a double dose to make up for a forgotten dose. Simply continue with the treatment.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Stop taking Tiorfan and contact a doctor immediately if you experience symptoms of angioedema, such as:
Stop using racecadotril and seek medical attention immediately if you notice any of the following symptoms:
The following side effects have been reported:
Common (may affect up to 1 in 10 people): headache.
Uncommon (may affect up to 1 in 100 people): rash and erythema (redness of the skin).
Frequency not known (frequency cannot be estimated from available data): erythema multiforme (red lesions on the extremities and inside the mouth), tongue swelling, facial swelling, lip swelling, eyelid swelling, urticaria, erythema nodosum (inflammation in the form of lumps under the skin), papular rash (skin rash with small, hard, and raised lesions), prurigo (skin lesions with itching), pruritus (generalized itching), and toxic skin rash.
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Monitoring System (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton after EXP.
The expiration date is the last day of the month indicated.
No special storage conditions are required. Medications should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Tiorfan
The active substance is racecadotril. Each capsule contains 100 mg of racecadotril.
The other ingredients are lactose, pregelatinized corn starch, magnesium stearate, and anhydrous colloidal silica. The capsule contains gelatin, yellow iron oxide (E 172), and titanium dioxide (E 171).
Appearance of Tiorfan and contents of the pack
Tiorfan is available in the form of hard ivory-colored capsules.
Each pack contains 6, 10, 20, 100, or 500 hard capsules. The 100 and 500 capsule packs are for clinical use.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
BIOPROJET-FERRER, S.L.
Gran Vía Carlos III, 94
08028 Barcelona (Spain)
Manufacturer
FERRER INTERNACIONAL, S.A.
Joan Buscallà 1-9
08173 Sant Cugat del Vallès, Barcelona (Spain)
or
SOPHARTEX,
21 rue de Pressoir,
28500 Vernouillet (France)
This medication is authorized in the Member States of the European Economic Area under the following names:
GERMANY: Tiorfan
PORTUGAL: Tiorfan
GREECE: Hidrasec
ITALY: Tiorfix
AUSTRIA: Hidrasec
BELGIUM: Tiorfix
CZECH REPUBLIC: Hidrasec
DENMARK: Hidrasec
ESTONIA: Hidrasec
FINLAND: Hidrasec
HUNGARY: Hidrasec
IRELAND: Hidrasec
LATVIA: Hidrasec
LITHUANIA: Hidrasec
LUXEMBOURG: Tiorfix
NETHERLANDS: Hidrasec
POLAND: Tiorfan
SLOVAKIA: Hidrasec
SLOVENIA: Hidrasec
SWEDEN: Hidrasec
UNITED KINGDOM: Hidrasec
This package leaflet was approved on 24-11-2024
Detailed and up-to-date information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es.